Paragon Capital Management (Utah)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-19,203
| Closed | -$1.26M | – | 75 |
|
2024
Q4 | $1.26M | Buy |
19,203
+10,507
| +121% | +$688K | 0.98% | 41 |
|
2024
Q3 | $678K | Buy |
+8,696
| New | +$678K | 0.5% | 57 |
|
2022
Q4 | – | Sell |
-18,250
| Closed | -$1M | – | 77 |
|
2022
Q3 | $1M | Buy |
18,250
+9,631
| +112% | +$528K | 0.98% | 35 |
|
2022
Q2 | $569K | Buy |
+8,619
| New | +$569K | 0.58% | 53 |
|